BJT-628

N/A

Report date: 2025/03/19 16:06:34

Base Information

Drug NameBJT-628
Drug Alias NameBJT-628
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHBsAg inhibitors
TargetsHepatitis B Surface Antigens
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBluejay Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBluejay Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A